In a recent study, offering support services soon after a patient’s diagnosis reduced depression among caregivers.
Research
Miguel Marin-Padilla: The Solitary Investigator
For nearly five decades, Geisel research Miguel Marin-Padilla has followed in the footsteps of Camillo Golgi by creating painstaking images that unravel the secrets of the brain.
First Survey of ACOs Reveals Surprising Level of Physician Leadership
In spite of early concerns that hospitals’ economic strengths would lead them to dominate the formation of Accountable Care Organizations (ACOs), a new study reveals the central role of physician leadership in the first wave of ACOs.
Mutation to BRCA2 Gene Can Double the Risk of Lung Cancer in Smokers
New research by an international group of scientists confirms a vulnerability to lung cancer can be inherited and implicates the BRCA2 gene as harboring one of the involved genetic mutations.
$13 Million Grant Will Fund Research on Toxic Metals
A $13 million, five-year grant will allow scientists at the Dartmouth Toxic Metals Superfund Research Program to continue and expand their research on the effects of exposure to arsenic, mercury, and other potential toxins on health.
Examining the Link Between Leptin and Infant Development
A close look at the hormone leptin has revealed a link between methylation of the leptin gene and the development of male infants. The study was led by associate professor Carmen Marsit and graduate student Corina Lesseur.
Achieving Patient-Centered Care Across the Spectrum
Dr. Glyn Elwyn of the Dartmouth Center for Health Care Delivery Science is the principal investigator of a study on the use of two methods—shared decision-making and motivational interviewing—when discussing options for treatment with patients.
Dartmouth Scientists Identify Genetic Blueprint for Cancers of the Appendix
Using next generation DNA sequencing, Dartmouth scientists have identified potentially actionable mutations in cancers of the appendix. When specific mutations for a cancer type are identified, patients can be treated with chemotherapy or other targeted agents that work on those mutations.
Tosteson named a Fellow of the American Statistical Association
Tor D. Tosteson, Sc.D., a Geisel professor of community and family medicine and of The Dartmouth Institute of Health Policy and Clinical Practice, has been selected as a Fellow of the American Statistical Association.
Dartmouth Chosen to Play Key Role in NCI Clinical Trials Network
Dartmouth will serve as a Lead Academic Participating Site in the National Cancer Institute’s (NCI) new National Clinical Trials Network (NCTN), which is intended to improve the speed and efficiency of conducting cancer clinical trials.